• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用地中海拟无枝酸菌进行利福霉素SV的固态发酵及生产。

Solid state fermentation and production of rifamycin SV using Amycolatopsis mediterranei.

作者信息

Nagavalli M, Ponamgi S P D, Girijashankar V, Venkateswar Rao L

机构信息

Department of Microbiology, Osmania University, Hyderabad, India.

出版信息

Lett Appl Microbiol. 2015 Jan;60(1):44-51. doi: 10.1111/lam.12332. Epub 2014 Nov 16.

DOI:10.1111/lam.12332
PMID:25256628
Abstract

UNLABELLED

Production of Rifamycin SV from cheaper agro-industrial by-products using mutant strain of Amycolatopsis mediterranei OVA5-E7 in solid state fermentation (SSF) was optimized. Among the agro-based substrates used, ragi bran was found suitable for maximizing the yield of Rifamycin SV (1310 mg 100 g(-1) ds). The yield can be further enhanced to 19·7 g Kg(-1) of dry substrate by supplementing the substrate with deoiled cotton cake (10% w/w) using optimized fermentation parameters such as maintaining 80% moisture, pH 7·0, 30°C incubation temperature, inoculum 25% v/w and carrying the solid state fermenting for 9 days. Manipulating these seven specifications, the end product yield achieved in our experimentation was 20 g of Rifamycin SV Kg(-1) ds. Eventually, an overall 5-fold improvement in Rifamycin SV production was achieved.

SIGNIFICANCE AND IMPACT OF THE STUDY

Antibiotics such as rifamycin are broad-spectrum antimicrobial drugs used in large-scale worldwide as human medicine towards controlling diseases. Amycolatopsis mediterranei strain which produces this antibiotic was earlier used in submerged fermentation yielded lower amounts of rifamycin. By employing cheaper agro-industrial by-products, we produced upto 20 g rifamycin SV per Kg dry substrate used under optimized solid state fermentation conditions. Keeping in view, the role of rifamycin in meeting the medical demands of world's increasing population; we successfully used an improved strain on cheaper substrates with optimized fermentation parameters and achieved a 5-fold improvement in rifamycin SV production.

摘要

未标记

利用地中海拟无枝酸菌OVA5 - E7突变株在固态发酵(SSF)中从更廉价的农业工业副产品生产利福霉素SV的过程得到了优化。在所使用的基于农业的底物中,发现ragi麸皮适合使利福霉素SV的产量最大化(1310毫克/100克干物质)。通过使用优化的发酵参数,如保持80%的湿度、pH值7.0、30°C的培养温度、25%(体积/重量)的接种量以及进行9天的固态发酵,向底物中添加脱油棉籽饼(10%重量/重量),产量可进一步提高到19.7克/千克干底物。通过控制这七个参数,我们实验中获得的最终产品产量为20克利福霉素SV/千克干物质。最终,利福霉素SV的产量总体提高了5倍。

研究的意义和影响

利福霉素等抗生素是在全球范围内作为人类药物用于控制疾病的广谱抗菌药物。 earlier用于深层发酵的地中海拟无枝酸菌菌株产生的利福霉素量较低。通过使用更廉价的农业工业副产品,我们在优化的固态发酵条件下,每千克干底物最多可生产20克利福霉素SV。考虑到利福霉素在满足世界不断增长的人口的医疗需求方面的作用;我们成功地在更廉价的底物上使用改良菌株并采用优化的发酵参数,使利福霉素SV的产量提高了5倍。 (注:原文中“earlier used in submerged fermentation yielded lower amounts of rifamycin”表述似乎不太完整通顺,可能存在一定语病,但按要求未做修改直接翻译。)

相似文献

1
Solid state fermentation and production of rifamycin SV using Amycolatopsis mediterranei.利用地中海拟无枝酸菌进行利福霉素SV的固态发酵及生产。
Lett Appl Microbiol. 2015 Jan;60(1):44-51. doi: 10.1111/lam.12332. Epub 2014 Nov 16.
2
Biosynthesis of rifamycin SV by Amycolatopsis mediterranei MTCC17 in solid cultures.地中海拟无枝酸菌MTCC17在固体培养物中合成利福霉素SV
Biotechnol Appl Biochem. 2003 Jun;37(Pt 3):311-5. doi: 10.1042/BA20020086.
3
Effect of uracil on rifamycin SV production by Amycolatopsis mediterranei MV35R.尿嘧啶对地中海拟无枝酸菌MV35R生产利福霉素SV的影响。
Lett Appl Microbiol. 2000 Jul;31(1):73-6. doi: 10.1046/j.1472-765x.2000.00769.x.
4
Enhanced rifamycin SV production by submerged fermentation using Amycolatopsis mediterranei.利用地中海拟无枝酸菌通过深层发酵提高利福霉素SV的产量。
Appl Microbiol Biotechnol. 2015 Sep;99(18):7505-13. doi: 10.1007/s00253-015-6682-2. Epub 2015 May 31.
5
MoeA, an enzyme in the molybdopterin synthesis pathway, is required for rifamycin SV production in Amycolatopsis mediterranei U32.MoeA是钼蝶呤合成途径中的一种酶,对于地中海拟无枝酸菌U32生产利福霉素SV是必需的。
Appl Microbiol Biotechnol. 2002 Oct;60(1-2):139-46. doi: 10.1007/s00253-002-1093-6. Epub 2002 Aug 22.
6
Improvement of industry-applied rifamycin B-producing strain, Amycolatopsis mediterranei, by rational screening.通过理性筛选改良工业应用的利福霉素B产生菌地中海拟无枝酸菌。
J Gen Appl Microbiol. 2002 Dec;48(6):329-34. doi: 10.2323/jgam.48.329.
7
Isolation and characterization of 27-O-demethylrifamycin SV methyltransferase provides new insights into the post-PKS modification steps during the biosynthesis of the antitubercular drug rifamycin B by Amycolatopsis mediterranei S699.27-O-去甲基利福霉素SV甲基转移酶的分离与鉴定为地中海拟无枝酸菌S699生物合成抗结核药物利福霉素B过程中聚酮合酶后修饰步骤提供了新见解。
Arch Biochem Biophys. 2003 Mar 15;411(2):277-88. doi: 10.1016/s0003-9861(03)00004-3.
8
Development of balanced medium composition for improved rifamycin B production by isolated Amycolatopsis sp. RSP-3.开发用于提高分离的游动放线菌RSP-3生产利福霉素B的平衡培养基成分。
Lett Appl Microbiol. 2009 Nov;49(5):533-8. doi: 10.1111/j.1472-765X.2009.02701.x. Epub 2009 Jul 21.
9
Scale-up of rifamycin B fermentation with Amycolatoposis mediterranei.利用地中海拟无枝酸菌扩大利福霉素B的发酵规模。
J Zhejiang Univ Sci. 2004 Dec;5(12):1590-6. doi: 10.1631/jzus.2004.1590.
10
Phase shifts in the stoichiometry of rifamycin B fermentation and correlation with the trends in the parameters measured online.利福霉素B发酵化学计量中的相移及其与在线测量参数趋势的相关性。
J Biotechnol. 2006 Dec 15;127(1):115-28. doi: 10.1016/j.jbiotec.2006.06.014. Epub 2006 Jun 30.

引用本文的文献

1
Valorization of agro-industrial waste through solid-state fermentation: Mini review.通过固态发酵实现农业工业废弃物的增值利用:小型综述
Biotechnol Rep (Amst). 2024 Dec 30;45:e00873. doi: 10.1016/j.btre.2024.e00873. eCollection 2025 Mar.
2
Description of sp. nov., an endophytic actinobacterium producing naphthomycin A and its genome insight for discovering bioactive compounds.产生萘霉素A的内生放线菌新种的描述及其用于发现生物活性化合物的基因组洞察
Front Microbiol. 2024 Apr 17;15:1353511. doi: 10.3389/fmicb.2024.1353511. eCollection 2024.
3
Improvement of beauvericin production by Fusarium oxysporum AB2 under solid-state fermentation using an optimised liquid medium and co-cultures.
利用优化的液体培养基和共培养物提高固态发酵中产 beauvericin 的镰孢菌 AB2。
Mycotoxin Res. 2022 Aug;38(3):175-183. doi: 10.1007/s12550-022-00458-y. Epub 2022 Apr 30.
4
Active pharmaceutical ingredient (API) chemicals: a critical review of current biotechnological approaches.原料药(API)化学品:当前生物技术方法的批判性回顾。
Bioengineered. 2022 Feb;13(2):4309-4327. doi: 10.1080/21655979.2022.2031412.
5
Production and statistical optimization of Paromomycin by Streptomyces rimosus NRRL 2455 in solid state fermentation.利用固态发酵生产和统计优化棘孢小单孢菌 NRRL 2455 产生的巴龙霉素。
BMC Microbiol. 2021 Jan 23;21(1):34. doi: 10.1186/s12866-021-02093-6.
6
Solid state fermentation (SSF): diversity of applications to valorize waste and biomass.固态发酵(SSF):用于废弃物和生物质增值的多种应用
3 Biotech. 2017 May;7(1):44. doi: 10.1007/s13205-017-0692-y. Epub 2017 Apr 25.